Colchicine, a well-known anti-inflammatory drug for gout, works well in the treatment of Covid-19. According to a new Canadian study. It would significantly reduce the risk of serious illness or death.
The announcement by the Canadian Institut de Cardiologie de Montréal (ICM) sparked global optimism last weekend. Colchicine is being touted as “the only effective oral drug to treat patients outside the hospital.”
Research in approximately 4,500 patients in Canada, the United States, South America, Europe and South Africa shows that the drug reduced the risk of death or illness by 21 percent compared to a placebo.
What makes the treatment especially attractive is that the pills can be taken at home and hospital admissions are thus avoided. “We offer a partial solution to reduce hospital admissions and potentially reduce congestion in the hospital system,” project leader Jean-Claude Tardif told AFP news agency.
According to doctors worldwide, this is an encouraging study, but we have to wait for the full scientific publication to get a definitive answer about its proper functioning. Last year, another hoped-for miracle drug, hydroxycholoroquine, ultimately turned out not to work.
Colchicine is a cheap anti-inflammatory drug that is mainly used in the treatment of gout. It is only available with a prescription from the pharmacist.
You can find the report from the researchers from Montreal here.